RUCH JOSHUA 4
4 · GeneDx Holdings Corp. · Filed Jan 22, 2025
Insider Transaction Report
Form 4
RUCH JOSHUA
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2025-01-17$7.89/sh+3,000$23,670→ 10,983 total - Exercise/Conversion
Stock Option (right to buy)
2025-01-17−3,000→ 5,816 totalExercise: $7.89Exp: 2033-07-20→ Class A Common Stock (3,000 underlying)
Holdings
- 14,845(indirect: By LLC)
Class A Common Stock
- 30,138(indirect: By LLC)
Class A Common Stock
- 149,284(indirect: See VAAL Investment Partners Q9 LP)
Class A Common Stock
Footnotes (3)
- [F1]Reflects an acquisition of Class A Common Stock from the exercise of stock option at an exercise price of $7.89 per share as described in Table II. The increase in beneficial ownership of Class A Common Stock resulting therefrom is indicated in Table I.
- [F2]Mr. Ruch is (i) a managing member of the managing member of the general partner of Vaal Investment Partners Q9 LP ("Q9"), (ii) a managing member of RUGU2 LLC ("RUGU2") and (iii) a managing member of Kariba LLC ("Kariba"). As such, Mr. Ruch exercises voting and investment power with respect to the shares owned by Q9, RUGU2 and Kariba. Mr. Ruch disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
- [F3]The option is fully vested.